Cell and Gene Therapy Conference 2024

Cell and Gene Therapy Conference 2024: Connect with our experts and find out how to unlock the full potential of your cell and gene therapies.

Connect with Intertek's gene therapy characterization experts during the premier international C&G events this year. We look forward to discussing the latest breakthroughs in discovery, clinical development, novel modalities, and much more with you. We can support your gene therapy development from an early stage, providing a broad range of cGMP, GLP, and GCP laboratory services, including method development, validation, and analysis to meet milestone and regulatory requirements. Meet us at the following conferences and dive into our cell & gene therapy insights:

Cell & Gene Therapy International event, in Boston, MA (September 23-26, 2024) - Part of Biotech Week Boston (BWB) event

BEBPA - 2024 European Bioassay Conference, in Prague, Czech Republic  (September 25-27, 2024)

Gene Therapy Analytical Development & CMC Summit, in Boston, MA (October 30 - November 1, 2024)

Advanced Therapies Week, in Dallas, TX (January 20-23, 2025)

Explore expert strategies for overcoming development hurdles, forging strategic partnerships, and unlocking the full potential of your cell and gene therapies. 

Connect with the Intertek C&G team >

Cell & Gene Therapy Insights:

BROCHURE | Cell and Gene Therapy Analytical Development Services
Take the Video Tour | Our Gene Therapy Analytical Expertise
Article | Assessing Critical Quality Attributes of Viral Vectors
Case Study | Determining the Proportion of DNA-Packaged and Empty Capsid Populations by Cryo-TEM in Adeno-associated Viruses
Article | Physicochemical Properties of Liposomal Advanced Drug Delivery Technologies
Webinar | A Comparison of qPCR and ddPCR Methods for Residual DNA Analysis

Looking forward to connecting with you at the cell and gene therapy conference in 2024 - in the meantime, please take a moment to learn more:
Our experts help you to confirm identity and ensure the product safety, quality, purity, potency and strength of your atmp or gene therapy product through GCP/GLP bioanalysis, stability storage and testing, compendial testing, viral vector characterisation, virology assays, aggregation analysis, cell-based assays / potency testing, QC release testing, advanced delivery technology analytical support and determination of residual proteins, DNA, RNA, cytokines, growth factors, serum, antibodies and solvents.